Allogene Therapeutics Inc (ALLO) — Cash Flow Reinvestment Rate
Latest as of March 2018:
63355.20x
Allogene Therapeutics Inc (ALLO) has a Cash Flow Reinvestment Rate of 63355.20x as of March 2018, reinvesting $316.78 Million (capex $1.38 Million plus investments $-315.40 Million) from operating cash flow of $5.00K. See ALLO free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
63355.20x
(Capex + Investments) / Operating CF
Total Reinvested
$316.78 Million
Capex + Investments
Operating Cash Flow
$5.00K
USD
Capital Expenditures
$1.38 Million
USD
Annual Cash Flow Reinvestment Rate for Allogene Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Allogene Therapeutics Inc. See Allogene Therapeutics Inc (ALLO) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow